Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 3/20 | 0.31 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 2/20 | 0.30 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.30 |
| ▸ | PHGDH | O43175 | 1/20 | 0.30 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.30 |
| ▸ | FBP1 | P09467 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23661365 | 1.00 | MLYCD (0.33) | MLYCDALDH1A1MEN1HPGDTSHR | |
| SCHEMBL23661367 | 0.98 | MLYCD (0.33) | MLYCD | |
| SCHEMBL23660967 | 0.85 | ALDH1A1 (0.38) | MLYCDALDH1A1MEN1HPGDTSHR | |
| SCHEMBL23660963 | 0.83 | MLYCD (0.38) | MLYCDALDH1A1MEN1HPGDTSHR | |
| SCHEMBL23661363 | 0.78 | MLYCD (0.36) | MLYCDALDH1A1MEN1KMT2ACA1 | |
| SCHEMBL17453100 | 0.76 | ALDH1A1 (0.35) | MLYCDALDH1A1MEN1HPGDTSHR | |
| SCHEMBL18942813 | 0.76 | ALDH1A1 (0.35) | MLYCDALDH1A1MEN1HPGDTSHR | |
| SCHEMBL23660971 | 0.75 | NAMPT (0.30) | — | |
| SCHEMBL17453108 | 0.73 | MLYCD (0.35) | MLYCDALDH1A1MEN1HPGDTSHR | |
| SCHEMBL9588108 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210221776-A1 | PERFLUOROAMINOOLEFINS AND METHODS OF MAKING AND USING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2021-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210221776-A1 | PERFLUOROAMINOOLEFINS AND METHODS OF MAKING AND USING THE SAME | FGB, RFTN1, AFF1 | MLYCD 3104/4885ALDH1A1 4051/4885MEN1 4176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.